JPMorgan ETFs (Ireland) ICAV - Europe Research Enhanced Index Equity UCITS ETF - EUR (acc) | JREERegistrer dig for at låse op for ratings |
Fondens performance | 31-03-2024 |
Vækst af 1.000 (DKK) | Avanceret graf |
Fond | -2,2 | 25,4 | -8,8 | 17,0 | 7,7 | |
+/-Kat | -0,6 | 2,6 | 4,4 | 2,5 | 0,5 | |
+/-Indeks | 1,1 | 0,1 | 0,8 | 0,9 | -0,1 | |
Kategori: Aktier - Europa Large Cap Blend | ||||||
Kategoribenchmark: Morningstar DM Eur TME NR EUR |
Oversigt | ||
Closing Price 19-04-2024 | EUR 41,35 | |
Kursændring 1 dag | -0,01% | |
Bud (18-04-2024) | EUR 41,23 | |
Udbud (18-04-2024) | EUR 41,23 | |
Morningstar Kategori™ | Aktier - Europa Large Cap Blend | |
Omsætning | 10 | |
Børs | LONDON STOCK EXCHANGE, THE | |
ISIN | IE00BF4G7183 | |
Markedsværdi i alt (mio.) 18-04-2024 | EUR 1332,34 | |
Seneste TNA(mio.) 18-04-2024 | EUR 1293,45 | |
Løbende omkostning 02-04-2024 | 0,25% | |
Investeringsstrategi | Aktiv |
Investeringsmålsætning: JPMorgan ETFs (Ireland) ICAV - Europe Research Enhanced Index Equity UCITS ETF - EUR (acc) | JREE |
The objective of the Sub-Fund is to achieve a long-term return in excess of the Benchmark by actively investing primarily in a portfolio of European companies. |
Returns | |||||||||||||
|
Management | ||
Manager navn Startdato | ||
Piera Grassi 14-05-2019 | ||
Nicholas Farserotu 30-06-2020 | ||
Startdato 10-10-2018 |
Annonce |
Kategoribenchmark | |
Fondens indeks | Morningstar indeks |
MSCI Europe NR EUR | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Formuefordeling JPMorgan ETFs (Ireland) ICAV - Europe Research Enhanced Index Equity UCITS ETF - EUR (acc) | JREE | 31-03-2024 |
|
|
Top 5 placeringer | Sektor | % |
Novo Nordisk A/S Class B | Healthcare | 4,36 |
ASML Holding NV | Teknologi | 4,19 |
Nestle SA | Forbrugsvarer | 3,27 |
Shell PLC | Olie og gas | 2,76 |
Lvmh Moet Hennessy Louis Vuitton SE | Cyklisk forbrug | 2,75 |
Øget Mindsket Ny siden sidste portefølje | ||
JPMorgan ETFs (Ireland) ICAV - Europe Research Enhanced Index Equity UCITS ETF - EUR (acc) | JREE |